Pregnancy outcome

Late Effects of Childhood Cancer

Volumn , Issue , 2004, Pages 257-266

  Green, Daniel M ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68149086351     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man: Chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv Cancer Res 1975; 22:57-155
2. Russell WL. Mutation frequencies in female mice and the estimation of genetic hazards of radiation in women. Proc Natl Acad Sci USA 1977; 74:3523-3527
3. Kirk KM, Lyon MF. Induction of congenital malformations in the offspring of male mice treated with x-rays at pre-meiotic and post-meiotic stages. Mutation Res 1984; 125:75-85
4. Matheson D, Brusick D, Carrano R. Comparison of the relative mutagenic activity for eight antineoplastic drugs in the Ames Salmonella/microsome and TK± mouse lymphoma assays. Drug Chem Toxicol 1978; 1:277-304
5. Benedict WF, Baker MS, Haroun L, et al. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test. Cancer Res 1977; 37:2209-2213
6. Seino Y, Nagao M, Yahagi T, et al. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92. Cancer Res 1978; 38:2148-2156
7. Auletta AE, Martz AG, Parmar AS. Mutagenicity of nitrosourea compounds for Salmonella typhimurium: Brief communication. J Natl Cancer Inst 1978; 60:1495-1497
8. Franza BR Jr, Oeschger NS, Oeschger MP, Schein PS. Mutagenic activity of nitrosourea antitumor agents. J Natl Cancer Inst 1980; 65:149-154
9. Anderson D, Styles JA. The bacterial mutation test. Br J Cancer 1978; 37:924-930
10. Matney TS, Nguyen TV, Connor TH, et al. Genotoxic classification of anticancer drugs. Terato Carcino Mutagen 1985; 5:319-328
11. Nguyen TV, Theiss JC, Matney TS. Exposure of pharmacy personnel to mutagenic antineoplastic drugs. Cancer Res 1982; 42:4792-4796
12. Puyeo C. Natulan induces forward mutations to L-arabinose resistance in Salmonella typhimurium. Mutation Res 1979; 67:189-192
13. Yajima N, Knodo, K, Morita K. Reverse mutation tests in Salmonella typhimurium and chromosomal aberration tests in mammalian cells in culture on fluorinated pyrimidine derivatives. Mutation Res 1981; 88:241-254
14. Trasler JM, Hales BF, Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature 1985; 316:144-146
15. Schull WJ. Effects of atomic radiation. A half-century of studies from Hiroshima and Nagasaki. New York: Wiley-Liss, Inc, 1995:243-271
16. Neel JV, Satoh C, Goriki K, et al. Search for mutations altering protein charge and/or function in children of atomic bomb survivors: Final report. Am J Hum Genet 1988; 42:663-676
17. Neel JV, Satoh C, Hamilton HB, et al. Search for mutations affecting protein structure in children of atomic bomb survivors: preliminary report. Proc Natl Acad Sci USA 1980; 77:4221-4225
18. Langlois RG, Bigbee WL, Kyoizumi S, et al. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science 1987; 236:445-448
19. Kyoizumi S, Nakamura N, Hakoda M, et al. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow cytometer. Cancer Res 1989; 49:581-588
20. Hakoda M, Akiyama M, Kyoizumi S, et al. Increased somatic cell mutant frequency in atomic bomb survivors. Mutation Res 1988; 201:39-49
21. Albertini RJ. Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutation Res 1985; 150:411-422
22. Shlono PH, Chung CS, Myrianthopoulos NC. Preconception radiation, intrauterine diagnostic radiation and childhood neoplasia. J Natl Cancer Inst 1980; 65:681-686
23. Kneale GW, Stewart AM. Pre-conception x-rays and childhood cancers. Br J Cancer 1980; 41:222-226
24. Nicholson HO. Cytotoxic drugs in pregnancy. J Obstet Gynaecol Brief Comm 1968; 75:307-312
25. Sokal JE, Lessmann EM. Effects of cancer chemotherapeutic agents on the human fetus. JAMA 1960; 172:1765-1771
26. Sweet DL, Kinzie J. Consequences of radiotherapy and antineoplastic therapy for the fetus. J Reprod Med 1976; 17:241-246
27. Daly H, McCann SR, Hanratty TD, Temperley IJ. Successful pregnancy during combination chemotherapy for Hodgkin’s disease. Acta Haematol 1980; 64:154-156
28. Nisce LZ, Tome MA, He S, et al. Management of coexisting Hodgkin’s disease and pregnancy. Am J Clin Oncol 1986; 9:146-151
29. Garrett MJ. Teratogenic effect of combination chemotherapy. Ann Intern Med 1974; 80:667(Letter)
30. Thomas PRM, Peckham MJ. The investigation and management of Hodgkin’s disease in the pregnant patient. Cancer 1976; 38:1443-1451
31. Milunsky A, Graef JW, Gaynor MF. Methotrexate-induced congenital malformations. J Pediatr 1968; 72:790-795
32. Dara P, Slater LM, Armentrout SA. Successful pregnancy during chemotherapy for acute leukemia. Cancer 1981; 47:845-846
33. Li FP, Jaffe N. Progeny of childhood cancer survivors. Lancet 1974; 2:707-709
34. Li FP, Fine W, Jaffe N, et al. Offspring of patients treated for cancer in childhood. J Natl Cancer Inst 1979; 62:1193-1197
35. Blatt J, Mulvihill JJ, Ziegler JL, et al. Pregnancy outcome following cancer chemotherapy. Am J Med 1980; 69:828-832
36. Green DM, Zevon MA, Lowrie G, et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991; 325:141-146
37. Green DM, Fiorello A, Zevon MA, et al. Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med 1997; 151:379-383
38. Holmes GE, Holmes FF. Pregnancy outcome of patients treated for Hodgkin’s disease. Cancer 1978; 41:1317-1322
39. Simon R. Statistical methods for evaluating pregnancy outcomes in patients with Hodgkin’s disease. Cancer 1980; 45:2890-2892
40. McKeen EA, Mulvihill JJ, Rosner F, Zarrabi MH. Pregnancy outcome in Hodgkin’s disease. Lancet 1979; 2:590(Letter)
41. Green DM, Fine WE, Li FP. Offspring of patients treated for unilateral Wilms’ tumor in childhood. Cancer 1982; 49:2285-2288
42. Li FP, Gimbrere K, Gelber RD, et al. Outcome of pregnancy in survivors of Wilms’ tumor. JAMA 1987; 257:216-219
43. Byrne J, Mulvihill JJ, Connelly RR, et al. Reproductive problems and birth defects in survivors of Wilms’ tumor and their relatives. Med Pediatr Oncol 1988; 16:233-240
44. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989; 43:399-402
45. Nicholson HS, Blask AN, Markle BM, et al. Uterine anomalies in Wilms’ tumor survivors. Cancer 1996; 78:887-891
46. Byrne J, Nussbaum-Blask A, Taylor WS, et al. Prevalence of Mullerian duct anomalies detected at ultrasound. Am J Med Genet 2000; 94:9-12
47. Byrne J, Nicholson HS. Excess risk for Mullerian duct anomalies in girls with Wilms tumor. Med Pediatr Oncol 2002; 38:258-259
48. Lilleyman JS. Male fertility after successful chemotherapy for lymphoblastic leukaemia. Lancet 1979; 2:1125 (Letter)
49. Moe PJ, Lethinen M, Wegelius R, et al. Progeny of survivors of acute lymphocytic leukemia. Acta Paediatr Scand 1979; 68:301-303
50. Nesbit ME, Krivit W, Robison L, Hammond D. A follow-up report of long-term survivors of childhood acute lymphoblastic or undifferentiated leukemia. J Pediatr 1979; 95:727-730
51. Ross GT. Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms. Cancer 1976; 37:1043-1047
52. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the childhood cancer survivor study: a multiinstitutional collaborative project. Med Pediatr Oncol 2002; 38:229-239
53. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer. A report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002; 187:1070-1080
54. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of partners of male survivors of childhood cancer. A report from the Childhood Cancer Survivor Study. J Clin Oncol 2003; 21:716-721
55. Green DM, Peabody EM, Nan B, et al. Pregnancy outcome after treatment for Wilms tumor. A report from the National Wilms Tumor Study Group. J Clin Oncol 2002; 20:2506-2513
56. Garber JE, Lynch EA, Meadows AT, et al. Pregnancy outcome after therapy of childhood cancer. Proc Am Soc Clin Oncol 1990; 9:290 (abstract)
57. Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology 2000; 11:161-166
58. Critchley HOD, Wallace WHB, Shalet SM, et al. Abdominal irradiation in childhood: the potential for pregnancy. Br J Obstet Gynecol 1992; 99:392-394
59. Critchley HOD. Factors of importance for implantation and problems after treatment for childhood cancer. Med Pediatr Oncol 1999; 33:9-14
60. Bath LE, Critchley HOD, Chambers SE, et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol 1999; 106:1265-1272
61. Kenney LB, Nicholson HS, Brasseux C, et al. Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia. A Children’s Cancer Group/National Institutes of health report. Cancer 1996; 78:169-176
62. Dodds L, Marrett LD, Tomkins DJ, et al. Case-control study of congenital anomalies in children of cancer patients. Br Med J 1993; 307:164-168
63. Hawkins MM. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 1991; 83:1643-1650
64. Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998; 62:45-52
65. Mulvihill JJ, Connelly RR, Austin DF, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987; 2:813-817
66. Hawkins MM, Draper GJ, Smith RA. Cancer among 1,348 offspring of childhood cancer. Int J Cancer 1989; 43:975-978
67. Sankila R, Olsen JH, Anderson H, et al. Risk of cancer among offspring of childhood cancer survivors. N Engl J Med 1998; 338:1339-1344
68. LeFloch O, Donaldson SS, Kaplan HS. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin’s disease. Cancer 1976; 38:2263-2268
69. Holmes GE. Personal communication, 1987
70. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin’s disease. N Engl J Med 1981; 304:1377-1382
71. Andrieu JM, Ochoa-Molina ME. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin’s disease. Cancer 1983; 52:435-438
72. Whitehead E, Shalet SM, Blackledge G, et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin’s disease. Cancer 1983; 52:988-993
73. Donaldson SS, Kaplan, HS. A survey of pediatric Hodgkin’s disease at Stanford University: Results of therapy and quality of survival. In: Rosenberg SA, Kaplan HS (eds) Malignant lymphomas. etiology, immunology, pathology, treatment. New York: Academic Press, 1982:571-590
74. Green DM, Hall B. Pregnancy outcome following treatment during childhood or adolescence for Hodgkin’s disease. Pediatr Hematol Oncol 1988; 5:269-277.